254 related articles for article (PubMed ID: 22086560)
1. Quantitative assessment of tumour associated neovascularisation in patients with liver cirrhosis and hepatocellular carcinoma: role of dynamic-CT perfusion imaging.
Ippolito D; Capraro C; Casiraghi A; Cestari C; Sironi S
Eur Radiol; 2012 Apr; 22(4):803-11. PubMed ID: 22086560
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma in cirrhotic liver disease: functional computed tomography with perfusion imaging in the assessment of tumor vascularization.
Ippolito D; Sironi S; Pozzi M; Antolini L; Ratti L; Alberzoni C; Leone EB; Meloni F; Valsecchi MG; Fazio F
Acad Radiol; 2008 Jul; 15(7):919-27. PubMed ID: 18572129
[TBL] [Abstract][Full Text] [Related]
3. Perfusion CT in cirrhotic patients with early stage hepatocellular carcinoma: assessment of tumor-related vascularization.
Ippolito D; Sironi S; Pozzi M; Antolini L; Invernizzi F; Ratti L; Leone EB; Fazio F
Eur J Radiol; 2010 Jan; 73(1):148-52. PubMed ID: 19054640
[TBL] [Abstract][Full Text] [Related]
4. Quantitative evaluation of CT-perfusion map as indicator of tumor response to transarterial chemoembolization and radiofrequency ablation in HCC patients.
Ippolito D; Fior D; Bonaffini PA; Capraro C; Leni D; Corso R; Sironi S
Eur J Radiol; 2014 Sep; 83(9):1665-71. PubMed ID: 24962900
[TBL] [Abstract][Full Text] [Related]
5. Intraobserver and Interobserver Agreement in the Evaluation of Tumor Vascularization With Computed Tomography Perfusion in Cirrhotic Patients With Hepatocellular Carcinoma.
Ippolito D; Casiraghi AS; Talei Franzesi C; Bonaffini PA; Fior D; Sironi S
J Comput Assist Tomogr; 2016; 40(1):152-9. PubMed ID: 26484957
[TBL] [Abstract][Full Text] [Related]
6. Characterization of hepatocellular carcinoma (HCC) lesions using a novel CT-based volume perfusion (VPCT) technique.
Kaufmann S; Horger T; Oelker A; Kloth C; Nikolaou K; Schulze M; Horger M
Eur J Radiol; 2015 Jun; 84(6):1029-35. PubMed ID: 25816994
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of dynamic contrast-enhanced CT with perfusion imaging in the quantitative assessment of tumor response to sorafenib in patients with advanced hepatocellular carcinoma: A feasibility study.
Ippolito D; Querques G; Okolicsanyi S; Franzesi CT; Strazzabosco M; Sironi S
Eur J Radiol; 2017 May; 90():34-41. PubMed ID: 28583645
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of hepatocellular carcinoma with computed tomography perfusion imaging.
Bayraktutan Ü; Kantarci A; Oğul H; Kizrak Y; Özyiğit Ö; Yüceler Z; Genç B; Özoğul B
Turk J Med Sci; 2014; 44(2):193-6. PubMed ID: 25536723
[TBL] [Abstract][Full Text] [Related]
9. Perfusion computed tomography for detection of hepatocellular carcinoma in patients with liver cirrhosis.
Fischer MA; Kartalis N; Grigoriadis A; Loizou L; Stål P; Leidner B; Aspelin P; Brismar TB
Eur Radiol; 2015 Nov; 25(11):3123-32. PubMed ID: 25903707
[TBL] [Abstract][Full Text] [Related]
10. Perfusion computed tomographic assessment of early hepatocellular carcinoma in cirrhotic liver disease: initial observations.
Ippolito D; Sironi S; Pozzi M; Antolini L; Ratti L; Meloni F; Invernizzi F; Valsecchi MG; Fazio F
J Comput Assist Tomogr; 2008; 32(6):855-8. PubMed ID: 19204443
[TBL] [Abstract][Full Text] [Related]
11. Assessment of tumor vascularization with functional computed tomography perfusion imaging in patients with cirrhotic liver disease.
Li JP; Zhao DL; Jiang HJ; Huang YH; Li DQ; Wan Y; Liu XD; Wang JE
Hepatobiliary Pancreat Dis Int; 2011 Feb; 10(1):43-9. PubMed ID: 21269934
[TBL] [Abstract][Full Text] [Related]
12. Multiparametric imaging for detection and characterization of hepatocellular carcinoma using gadoxetic acid-enhanced MRI and perfusion-CT: which parameters work best?
Kurucay M; Kloth C; Kaufmann S; Nikolaou K; Bösmüller H; Horger M; Thaiss WM
Cancer Imaging; 2017 Jun; 17(1):18. PubMed ID: 28659180
[TBL] [Abstract][Full Text] [Related]
13. Differences Between CT-Perfusion and Biphasic Contrast-enhanced CT for Detection and Characterization of Hepatocellular Carcinoma: Potential Explanations for Discrepant Cases.
Perl RM; Portugall J; Hinterleitner C; Hinterleitner M; Kloth C; Walter SS; Bitzer M; Horger MS
Anticancer Res; 2021 Mar; 41(3):1451-1458. PubMed ID: 33788737
[TBL] [Abstract][Full Text] [Related]
14. Tumour-related neoangiogenesis: functional dynamic perfusion computed tomography for diagnosis and treatment efficacy assessment in hepatocellular carcinoma.
Ippolito D; Fior D; Franzesi CT; Capraro C; Casiraghi A; Leni D; Vacirca F; Corso R; Sironi S
Dig Liver Dis; 2014 Oct; 46(10):916-22. PubMed ID: 25023006
[TBL] [Abstract][Full Text] [Related]
15. Arterio-portal shunts in the cirrhotic liver: perfusion computed tomography for distinction of arterialized pseudolesions from hepatocellular carcinoma.
Fischer MA; Marquez HP; Gordic S; Leidner B; Klotz E; Aspelin P; Alkadhi H; Brismar TB
Eur Radiol; 2017 Mar; 27(3):1074-1080. PubMed ID: 27368924
[TBL] [Abstract][Full Text] [Related]
16. Can dual-energy CT replace perfusion CT for the functional evaluation of advanced hepatocellular carcinoma?
Mulé S; Pigneur F; Quelever R; Tenenhaus A; Baranes L; Richard P; Tacher V; Herin E; Pasquier H; Ronot M; Rahmouni A; Vilgrain V; Luciani A
Eur Radiol; 2018 May; 28(5):1977-1985. PubMed ID: 29168007
[TBL] [Abstract][Full Text] [Related]
17. Liver perfusion CT during hepatic arteriography for the hepatocellular carcinoma: dose reduction and quantitative evaluation for normal- and ultralow-dose protocol.
Watanabe S; Katada Y; Gohkyu M; Nakajima M; Kawabata H; Nozaki M
Eur J Radiol; 2012 Dec; 81(12):3993-7. PubMed ID: 22980216
[TBL] [Abstract][Full Text] [Related]
18. [Diagnostic value of computed tomographic perfusion imaging of whole liver for quantitative assessment of blood flow state in liver cancer after transcatheter arterial chemoembolization].
Li SM; Gao ZL; Lyu XT; Jia J; Zhu P; Chen Y; Liu YL; Zhang ZX
Zhonghua Gan Zang Bing Za Zhi; 2018 Jun; 26(6):429-435. PubMed ID: 30317756
[No Abstract] [Full Text] [Related]
19. Multiphasic Dynamic Computed Tomography Evaluation of Liver Tissue Perfusion Characteristics Using the Dual Maximum Slope Model in Patients With Cirrhosis and Hepatocellular Carcinoma: A Feasibility Study.
Lee DH; Lee JM; Klotz E; Han JK
Invest Radiol; 2016 Jul; 51(7):430-4. PubMed ID: 26756941
[TBL] [Abstract][Full Text] [Related]
20. Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue--initial experience.
Sahani DV; Holalkere NS; Mueller PR; Zhu AX
Radiology; 2007 Jun; 243(3):736-43. PubMed ID: 17517931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
